E M V M Silva1, R H W Lacerda1, I L Farias1, B G N Cavalcante1, I O Assis1, M Bezamat2, A Modesto3, Alexandre Rezende Vieira4,5. 1. Post-graduate Program in Dentistry and Center for Treatment of Cleft Lip and Palate, University Hospital Lauro Wanderley, Universidade Federal da Paraíba, João Pessoa, PB, Brazil. 2. Department of Oral Biology, School of Dental Medicine, University of Pittsburgh, 412 Salk Pavilion, 335 Sutherland Street, Pittsburgh, PA, 15261, USA. 3. Department of Pediatric Dentistry, School of Dental Medicine, University of Pittsburgh, Pittsburgh, PA, USA. 4. Post-graduate Program in Dentistry and Center for Treatment of Cleft Lip and Palate, University Hospital Lauro Wanderley, Universidade Federal da Paraíba, João Pessoa, PB, Brazil. arv11@pitt.edu. 5. Department of Oral Biology, School of Dental Medicine, University of Pittsburgh, 412 Salk Pavilion, 335 Sutherland Street, Pittsburgh, PA, 15261, USA. arv11@pitt.edu.
Abstract
PURPOSE: Verifying whether the mutation in COMT rs4818 could be involved in pain modulation. METHODS: Thirty-two individuals born with cleft lip and palate that underwent bone graft from the iliac crest bone were assessed at 12, 24, 48, 72 h, and 7 days regarding their pain experience using a visual analogic scale. DNA from each participant was collected from saliva samples, and genotyping of rs4818 was performed using TaqMan chemistry. Overrepresentation of rs4818 alleles was tested using chi-square or Fisher's exact tests with an alpha of 0.05. RESULTS: Of the 32 individuals, eighteen reported long pain duration, nine reported high pain intensity, and fourteen low pain intensity up to 48 h. No differences were found in the distribution of individuals depending on the reported pain by sex (p = 0.12), age (p = 0.42), or cleft type (p = 0.5). The distribution of COMT r4818 alleles was different depending on the intensity and duration of pain. Carriers of the C wild-type allele were four times more likely to show high pain intensity and duration (odds ratio = 4.29, 95% confidence interval 1.13-16.18), meaning that the G variant allele is protective. CONCLUSION: COMT rs4818 is associated with postoperative pain after alveolar bone grafting.
PURPOSE: Verifying whether the mutation in COMT rs4818 could be involved in pain modulation. METHODS: Thirty-two individuals born with cleft lip and palate that underwent bone graft from the iliac crest bone were assessed at 12, 24, 48, 72 h, and 7 days regarding their pain experience using a visual analogic scale. DNA from each participant was collected from saliva samples, and genotyping of rs4818 was performed using TaqMan chemistry. Overrepresentation of rs4818 alleles was tested using chi-square or Fisher's exact tests with an alpha of 0.05. RESULTS: Of the 32 individuals, eighteen reported long pain duration, nine reported high pain intensity, and fourteen low pain intensity up to 48 h. No differences were found in the distribution of individuals depending on the reported pain by sex (p = 0.12), age (p = 0.42), or cleft type (p = 0.5). The distribution of COMT r4818 alleles was different depending on the intensity and duration of pain. Carriers of the C wild-type allele were four times more likely to show high pain intensity and duration (odds ratio = 4.29, 95% confidence interval 1.13-16.18), meaning that the G variant allele is protective. CONCLUSION: COMT rs4818 is associated with postoperative pain after alveolar bone grafting.
Entities:
Keywords:
Bone graft; COMT; Cleft lip and palate; Genetics; Pain
Authors: G D Slade; A E Sanders; R Ohrbach; E Bair; W Maixner; J D Greenspan; R B Fillingim; S Smith; L Diatchenko Journal: J Dent Res Date: 2015-07-21 Impact factor: 6.116
Authors: Kyle M Baumbauer; Divya Ramesh; Mallory Perry; Katherine B Carney; Thomas Julian; Nicole Glidden; Susan G Dorsey; Angela R Starkweather; Erin E Young Journal: Clin J Pain Date: 2020-06 Impact factor: 3.442
Authors: T D Nascimento; N Yang; D Salman; H Jassar; N Kaciroti; E Bellile; T Danciu; R Koeppe; C Stohler; J K Zubieta; V Ellingrod; A F DaSilva Journal: J Dent Res Date: 2019-09-06 Impact factor: 8.924
Authors: Fernando Estévez-López; Juan M Guerrero-González; Diego Salazar-Tortosa; Daniel Camiletti-Moirón; Blanca Gavilán-Carrera; Virginia A Aparicio; Pedro Acosta-Manzano; Inmaculada C Álvarez-Gallardo; Víctor Segura-Jiménez; Alberto Soriano-Maldonado; Rinie Geenen; Manuel Delgado-Fernández; Luis J Martínez-González; Jonatan R Ruiz; María J Álvarez-Cubero Journal: Rheumatology (Oxford) Date: 2022-08-03 Impact factor: 7.046